GPD1L may inhibit the development of esophageal squamous cell carcinoma through the PI3K/AKT signaling pathway: bioinformatics analysis and experimental exploration

LanLan Gan,Lu Zhou,ALan Chu,Chen Sun,YongTai Wang,MengLin Yang,ZongWen Liu
DOI: https://doi.org/10.1007/s11033-024-10070-1
IF: 2.7422
2024-11-21
Molecular Biology Reports
Abstract:Esophageal squamous carcinoma (ESCC) is the most prevalent pathological subtype of esophageal cancer (EC). It has the characteristics of significant local invasion, quick disease progression, high recurrence rates, and a dismal prognosis for survival. Phosphatidylinositol 3-kinase/serine-threonine kinase (PI3K/AKT) is a signaling system whose aberrant activation regulates downstream factors, leading to the promotion of cancer development. This study looks at a protein called Glycerol-3-phosphate dehydrogenase 1-like (GPD1L), which strongly affects the development of several cancers. However, its association with ESCC development and its underlying mechanisms are not clear.
biochemistry & molecular biology
What problem does this paper attempt to address?